Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Dec 31, 2024
Open Peer Review Period: Dec 24, 2024 - Feb 18, 2025
Date Accepted: Jun 6, 2025
(closed for review but you can still tweet)
The Impact of Health Warnings in E-cigarette Content on Instagram on Adults’ E-Cigarette Cognitions: An Online Between-Subjects Experiment.
ABSTRACT
Background:
E-cigarette use is a growing public health concern, with these products being marketed by social media influencers on Instagram. Influencers promote e-cigarettes using misleading relative harm claims, portraying them as safer than regular cigarettes, while overstating benefits and selectively omitting information on the harms. To counter this, the U.S. Federal Drug Administration (FDA) requires influencers to include a nicotine warning label in their sponsored posts, similar to the ones used on e-cigarette packages. However, research on their effectiveness remains limited, leaving questions about when, how, and for whom these warnings work.
Objective:
This study examined how (a) relative harm claims and (b) health warnings in influencers’ sponsored e-cigarette content influence, health outcome expectations, and intentions to use e-cigarettes. Additionally, we investigated whether user status (i.e., smoking cigarettes and/or vaping e-cigarettes vs non-use) moderate these effects.
Methods:
Participants (n = 597, Mage = 40,84, SDage = 11,93) were recruited through a survey company using a quote-based sample of German adults aged 18-60, stratified by age, gender, and education. We conducted a pre-registered 2 (relative harm claim: absent or present) × 2 (health warning: absent or present) between-subjects experiment. Participants viewed Instagram profiles of two influencers and separate posts including sponsored e-cigarette content. Relative harm claims in sponsored e-cigarette posts were manipulated by adding captions stating that e-cigarettes are healthier than cigarettes, with misleading information about why this could be the case. Neutral captions described product features in the other condition. Health warnings appeared as a black-white box containing a nicotine warning statement. Participants then reported measures on attitudes, outcome expectations, intentions, and personal e-cigarette and cigarette use. Multivariate analysis of covariance and moderated mediation analyses were used to test the direct and interaction effects of misleading relative harm claims and health warnings.
Results:
Misleading relative harm claims significantly influenced health outcome expectations (F(1, 551) = 5.88, P = .016, η2p = .011), with participants exposed to harm claims about e-cigarettes reporting lower negative outcomes (M = 5.25 , SD = .09) compared to those who did not (M = 5.58, SD = .10). Health warnings had no significant effect on attitudes, health outcome expectations, or intentions. No interaction effect between health warnings and relative harm claims was observed. Overall user status (i.e., cigarette/ e-cigarette use vs non-use) did not moderate these effects.
Conclusions:
Health warnings as mandated by the FDA were ineffective in reducing the persuasive impact of influencers’ appealing e-cigarette content, regardless of an individual’s own experiences with cigarettes/ e-cigarettes. Policymakers should consider tailoring warnings that address audience-specific consequences to make them more effective. Additionally, media literacy interventions are essential to counter misleading relative harm claims and appealing influencers’ e-cigarette content. Clinical Trial: Not applicable
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.